Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
Shape-morphing microrobots deliver drugs to cancer cells
Chemotherapy successfully treats many forms of cancer, but the side effects can wreak havoc on…
Commentary highlights reasons for lack of diversity in cancer research
A commentary by researchers from Mayo Clinic and the University of Southern California, USA, suggests…
Researchers discover unique metabolic vulnerabilities of subsets of triple-negative breast cancer
Researchers have identified a metabolic enzyme and pathway in some triple-negative breast cancer (TNBC) patients,…
Working toward personalised cancer treatment
“We don’t just want to find the genes involved in cancer,” says Prof. Yardena Samuels of the Weizmann Institute of…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.